Influence of the dialysis membrane on markers of tissue ischemia

Journal of Investigative Medicine

Volumn 54, Issue 2, 2006, Pages 62-66

  Carrega, Louis ^a,b   Giaime, Philippe ^a,c   Montserrat, Colette ^b   Vincente, Olivia ^a   Brunei, Philippe ^c   Dussol, Bertrand ^c   Berland, Yvon ^c   Guieu, Regis ^a,b  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Adenosine; Hemodialysis; Ischemia modified albumin

Indexed keywords

ADENOSINE; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; FEMALE; HEMOCONCENTRATION; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; ISCHEMIA; KIDNEY FAILURE; MALE;

EID: 33644788466     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/6650.2006.05033     Document Type: Article

References (43)

1. Charney DI, Walton DF, Cheung AK. Atherosclerosis in chronic renal failure. Curr Opin Nephrol Hypertens 1993;2:876-82.
2. Ritz E, Deppisch R, Stier E, Hansch G. Atherogenesis and cardiac death: are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant 1994;9Suppl 2:165-72.
3. London GM. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function. J Am Soc Nephrol 2003;14 Suppl:305-9.
4. Shinzato T, Miwa M, Nakai S, et al. Role of adenosine in dialysis-induced hypotension. J Am Soc Nephrol 1994;4:1987-994.
5. Shinzato T, Nakai S, Odani H, et al. Relationship between dialysis induced hypotension and adenosine released by ischemic tissue. ASAIO J 1992;38:M286-90.
6. Yoshimitsu T, Hirakata H, Fujii K, et al. Cerebral ischemia as a causative mechanism for rapid progression of brain atrophy in chronic hemodialysis patients. Clin Nephrol 2000;53:445-51.
7. Nishimura M, Hashimoto T, Kobayashi H, et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 2004;66:811-9.
8. Plagemann PG. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate. J Cell Physiol 1986;128:491-500.
9. Paganelli F, Barnay P, Imbert-Joscht I, et al. Influence of residual myocardial ischaemia on induced ventricular arrhythmias following a first acute myocardial infarction. Eur Heart J 2001;22:1931-7.
10. Sollevi A. Cardiovascular effects of adenosine in man; possible clinical implications. Prog Neurobiol 1986;27:319-49.
11. Berne RM. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 1963;204:317-22.
12. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-5.
13. Painter PC, Branham E, Morris D, et al. Analytical studies of an assay to detect myocardial ischemia. Clin Chem 2001;46:A75.
14. Bar-Or D, Winkler JV, Vanbenthuysen K, et al. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001;141:985-91.
15. Guieu R, Brunet P, Sampol J, et al. Adenosine and hemodialysis in humans. J Invest Med 2001;49:56-67.
16. Sampol J, Dussol B, Fenouillet E, et al. High adenosine and deoxyadenosine concentrations in mononuclear cells of hemodialyzed patients. J Am Soc Nephrol 2001;12:1721-8.
17. Guieu R, Sampieri F, Bechis G, Rochat H. Use of HPLC to measure circulating adenosine levels in migrainous patients. Clin Chim Acta 1994;227:185-94.
18. Lee PT, Fang HC, Chen CL, et al. High vibration perception threshold and autonomic dysfunction in hemodialysis patients with intradialysis hypotension. Kidney Int 2003;64:1089-94
19. Jakob SM, Ruokonen E, Vuolteenaho O, et al. Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med 2001;29:1393-8.
20. Brengelmann GL. Circulatory adjustments to exercise and heat stress. Annu Rev Physiol 1983;45:191-212.
21. Olsson RA. Changes in content of purine nucleoside in canine myocardium during coronary occlusion. Circ Res 1970;26:301-6.
22. Paganelli F, Saadjian A, Sampol JJ, et al. Effects of percutaneous transluminal coronary angioplasty on coronary adenosine concentrations in humans. Eur J Clin Invest 2000;30:105-10.
23. Dussol B, Fenouillet E, Brunet P, et al. Kinetic study of adenosine concentrations and the expression of adenosine deaminase in mononuclear cells during hemodialysis. Kidney Int 2004;66:1640-6.
24. Sadler PJ, Tucker A, Viles JH. Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and A13+. Eur J Biochem 1994;220:193-200.
25. Masuoka J, Hegenauer J, Van Dyke BR, Saltman P. Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) andcopper(II) to the high affinity site of serum albumin. J Biol Chem 1993;268:21533-7.
26. Bar-Or D, Curtis G, Rao N, et al. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001;268:42-7.
27. Chan B, Dodsworth N, Woodrow J, et al. Site-specific N-terminal auto-degradation of human serum albumin. Eur J Biochem 1995;227:524-8.
28. Roy D, Quiles J, Aldama G, et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004;97:297-301.
29. Sinha MK, Gaze DC, Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5.
30. Diris JH, Hackeng CM, Kooman JP, et al. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004;109:23-5.
31. Ie EH, Hootwijk PJ, Weimar W, Zietse R. Significance of acute versus chronic troponin T elevation in dialysis patients. Nephron Clin Pract 2004;98:c87-92.
32. Tarakcioglu M, Erbagci A, Cekmen M, et al. Acute effect of haemodialysis on serum markers of myocardial damage. Int J Clin Pract 2002;56:328-32.
33. Dahlberg PJ, Kisken WA, Newcomer KL, Yutuc WR. Mesenteric ischemia in chronic dialysis patients. Am J Nephrol 1985;5:327-32.
34. Dumazer P, Dueymes JM, Vernier I, et al. [Non-occlusive mesenteric ischemia in patients undergoing maintenance hemodialysis]. Presse Med 1989;18:471-4.
35. Gusmao L, Santana A, Riocarvalho I, et al. Mesenteric ischemia in hemodialysis. Acta Med Port 1992;5:169-71.
36. Berger A, Mamzer-Bruneel MF, Wind P, et al. Opaque enema CT scan allows early diagnosis of non-occlusive right colonic ischaemia in dialysis patients. Nephrol Dial Transplant 1997;12:2179-81.
37. Ebel H, Laage C, Keuchel M, et al. Impact of profile haemodialysis on intra-/extracellular fluid shifts and the release of vasoactive hormones in elderly patients on regular dialysis treatment. Nephron 1997;75:264-71.
38. Singh NP, Banal R, Thakur A, et al. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study. Ren Fail 2003;25:419-30.
39. Amore A, Bonaudo R, Ghigo D, et al. Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol 1995;6:1278-83.
40. Rysz J, Liciak M, Kedziora J, et al. Nitric oxide release in the peripheral blood during hemodialysis. Kidney Int 1997;51:294-300.
41. Borgdorff P, Fekkes D, Tangelder GL. Hypotension caused by extracorporeal circulation; serotonin from pump-activated platelets triggers nitric oxide release. Circulation 2002;106:2588-93.
42. Hansen PB, Schnermann J. Vasoconstrictor and vasodilator effects of adenosine in the kidney. Am J Physiol Renal Physiol 2003;285:F590-9.
43. Raj DS, Vincent B, Simpson K, et al. Hemodynamic changes during hemodialysis: role of nitric oxide and endothelin. Kidney Int 2002;61:697-704.